153 related articles for article (PubMed ID: 35216960)
21. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
[No Abstract] [Full Text] [Related]
22. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.
Hoffmann J; Rother M; Kaiser U; Thrun MC; Wilhelm C; Gruen A; Niebergall U; Meissauer U; Neubauer A; Brendel C
Cytometry B Clin Cytom; 2020 Nov; 98(6):476-482. PubMed ID: 32716606
[TBL] [Abstract][Full Text] [Related]
23. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia.
Mora A; Bosch R; Cuellar C; Vicente EP; Blanco L; Martino R; Ubeda JM; Sierra J; Moreno C; Nomdedeu J
Cytometry B Clin Cytom; 2019 Mar; 96(2):143-148. PubMed ID: 30328261
[TBL] [Abstract][Full Text] [Related]
24. Utilization of a scoring system for diagnosis of chronic lymphocytic leukemia in Thai patients.
Promsuwicha O; Songmuang W; Auewarakul CU
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S232-8. PubMed ID: 21721452
[TBL] [Abstract][Full Text] [Related]
25. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.
Salem DA; Scott D; McCoy CS; Liewehr DJ; Venzon DJ; Arons E; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Cytometry B Clin Cytom; 2019 Jul; 96(4):275-282. PubMed ID: 31077558
[TBL] [Abstract][Full Text] [Related]
26. A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia.
Mehrpouri M; Sadat Hosseini M; Jafari L; Mosleh M; Shahabi Satlsar E
Iran Biomed J; 2023 Jan; 27(1):15-22. PubMed ID: 36624655
[TBL] [Abstract][Full Text] [Related]
27. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry.
Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA
Int J Lab Hematol; 2018 Oct; 40(5):533-539. PubMed ID: 29806244
[TBL] [Abstract][Full Text] [Related]
28. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
29. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
[TBL] [Abstract][Full Text] [Related]
30. Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia.
Salem DA; Stetler-Stevenson M
Methods Mol Biol; 2019; 2032():311-321. PubMed ID: 31522426
[TBL] [Abstract][Full Text] [Related]
31. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia.
Geisler CH; Larsen JK; Hansen NE; Hansen MM; Christensen BE; Lund B; Nielsen H; Plesner T; Thorling K; Andersen E
Blood; 1991 Oct; 78(7):1795-802. PubMed ID: 1717071
[TBL] [Abstract][Full Text] [Related]
32. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of the CLLflow score.
Sorigue M; Franch-Sarto M; Sarrate E; Junca J
Cytometry B Clin Cytom; 2018 Nov; 94(6):950-952. PubMed ID: 29316199
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Diagnostic Usefulness of CD200 Expression in B-cell Chronic Lymphoproliferative Disorders.
Purohit A; Satiza M; Somasundaram V; Sharma R; Mishra P; Seth T; Tyagi S; Mahapatra M; Pati HP; Saxena R
Indian J Hematol Blood Transfus; 2023 Oct; 39(4):684-690. PubMed ID: 37786819
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
McCarron KF; Hammel JP; Hsi ED
Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
[TBL] [Abstract][Full Text] [Related]
36. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
[TBL] [Abstract][Full Text] [Related]
37. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma.
Kilo MN; Dorfman DM
Am J Clin Pathol; 1996 Apr; 105(4):451-7. PubMed ID: 8604687
[TBL] [Abstract][Full Text] [Related]
38. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
[TBL] [Abstract][Full Text] [Related]
39. Independent diagnostic utility of CD20, CD200, CD43 and CD45 in chronic lymphocytic leukaemia.
Ramalingam TR; Mohanraj S; Muthu A; Prabhakar V; Ramakrishnan B; Vaidhyanathan L; Easow J; Raja T
Leuk Lymphoma; 2022 Feb; 63(2):377-384. PubMed ID: 34676804
[TBL] [Abstract][Full Text] [Related]
40. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.
Sandes AF; de Lourdes Chauffaille M; Oliveira CR; Maekawa Y; Tamashiro N; Takao TT; Ritter EC; Rizzatti EG
Cytometry B Clin Cytom; 2014 Mar; 86(2):98-105. PubMed ID: 24243815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]